Table 1:

Demographic and clinical features

Patients with MS (n = 53)Healthy Controls (n = 24)P Value
Female (No.) (%)34 (64.2%)16 (66.7%).830
Mean age (yr)43.64 (SD, 12.58)38.12 (SD, 13.2).642
RRMS (No.) (%)40 (75.5%)NANA
Mean disease duration (yr)9.91 (SD, 10.56)NANA
EDSS (median) (range)2.0 (0–7.0)NANA
ARMSS (mean) (SD)3.99 (SD, 2.32)NANA
Treatment
 No therapy (No.) (%)9 (17%)NANA
 Low-efficacy DMT (No.) (%)10 (19%)NANA
 High-efficacy DMT (No.) (%)34 (64%)NANA
  • Note:—RRMS indicates relapsing-remitting MS; NA, not applicable; DMT, disease-modifying therapy.